Vikram Thermo India Ltd.  BSE  
155.05 +0.85 (+0.55%)   12:15 AM (UTC +5:30)
Latest - June 16, 2025
New R&D Facility Expands Our Innovation Capabilities
Latest - June 16, 2025
New R&D Facility Expands Our Innovation Capabilities
Latest - June 16, 2025
New R&D Facility Expands Our Innovation Capabilities
Latest - June 16, 2025
New R&D Facility Expands Our Innovation Capabilities
Latest - June 16, 2025
New R&D Facility Expands Our Innovation Capabilities
Latest - June 16, 2025
New R&D Facility Expands Our Innovation Capabilities

Learn more

Enteric coating

Why enteric coating matters?
Protects actives in gastric acid and reduces irritation. L&S grades dissolve above set pH, enabling intestinal release with better stability and patient comfort.
Key benefits

Features that matter

pH-specific release: 5.5–7.0
Aqueous or solvent processing
Smooth films with strong adhesion
Lot-to-lot performance consistency
USP/NF & Ph. Eur aligned
Scales from trials to commercial
Solution series

Enteric coating

DRUGCOAT SERIES MONOGRAPHS PHYSICAL FORM DISSOLUTION PROPERTIES
Aqueous enteric coating
DRUGCOAT L30D USP/NF: Methacrylic Acid and Ethyl Acrylate Copolymer Dispersion
Ph. Eur: Methacrylic Acid–Ethyl Acrylate Copolymer (1:1) Dispersion 30%
Aqueous Dispersion 30% Dissolve above pH 5.5
DRUGCOAT L100-55 USP/NF: Methacrylic Acid–Ethyl Acrylate Copolymer
Ph. Eur.: Methacrylic Acid- Ethyl Acrylate Copolymer (1:1) Type A
Powder
DRUGCOAT L100-55D USP/NF: Partially Neutralized Methacrylic Acid & Ethyl Acrylate Copolymer
Ph. Eur: Methacrylic Acid–Ethyl Acrylate Copolymer (1:1) Type B
Non-aqueous enteric coating
DRUGCOAT L100 USP/NF: Methacrylic Acid and Methyl Methacrylate Copolymer (1:1)
Ph. Eur: Methacrylic Acid – Methyl Methacrylate Copolymer (1:1)
Powder Dissolve above pH 6.0
DRUGCOAT L12.5 Organic Solution 12.5%
Colon targeted enteric coating
DRUGCOAT S100 USP/NF: Methacrylic Acid and Methyl Methacrylate Copolymer (1:2)
Ph. Eur: Methacrylic Acid – Methyl Methacrylate Copolymer (1:2)
Powder Dissolve above pH 7.0
DRUGCOAT S12.5 Organic Solution 12.5%
DRUGCOAT FS 30D USP/NF : Methyl Acrylate, Methyl Methacrylate and Methacrylic Acid (7:3:1) Copolymer Dispersion. Aqueous Dispersion 30%
accreditations

Certified to perform globally

2015
EXCiPACT Certified
First in India to get EXCiPACT international GMP Certified
2024
US DMF Available
Registered in US Drug Master File.
2014
ISO 9001 Certified
Certified for quality management.
2005
WHO cGMP Compliance
Complies with WHO cGMP standards
2005
HALAL Certified
HALAL certified excipients.
FAQs

A few questions answered

  • What are the benefits of using enteric-coated granules in pharmaceuticals?
    Enteric coated granules delay release until they reach the intestines, ideal for delayed release capsule technologies. This improves drug bioavailability, patient experience, and therapeutic efficiency.
  • Could you explain the process of applying enteric coating?
    The process involves applying a polymer film coating or solution to the dosage form, ensuring durability. This allows targeted release as seen in bisacodyl enteric coated tablets and digestive enteric coated tablet applications.
  • How does enteric coating enable controlled drug release?
    By using polymers that resist stomach acid and dissolve in alkaline intestines, enteric coating achieves gradual, controlled release in both film coated and enteric coated drugs.
  • What is the purpose of enteric coating in drug delivery systems?
    Enteric coating provides enteric protection, prevents gastric irritation, and ensures precise release at the intended intestinal site of action for enteric coated antibiotics and other sensitive drugs.
  • Which polymers are commonly used for enteric coating?
    Polymers such as Methacrylate Copolymers, Methacrylic Acid Copolymers, and Acrylate Copolymers are the most common, as they ensure precision in enteric coated formulation.
  • What is enteric coating, and why is it used for tablets and capsules?
    Enteric coating is a protective layer applied to enteric coated tablets, enteric coated caplets, and enteric coated capsules to shield them from stomach acid, ensuring release in the intestines. This mechanism is crucial for enteric coated drug formulations requiring pH-sensitive dissolution.
  • Let’s take a step for your next product
    How can we reach you?*
    Any specific product?*
    Tell us about your requirement.*
    Thank you! Your submission has been received!
    Oops! Something went wrong while submitting the form.
    Keep exploring
    DRUGCOAT® Series
    DRCOAT® Series
    AQUAPOL® Series
    APION® Series